Lipocalin 2: a potential therapeutic target for breast cancer metastasis

Although systematic therapeutic approaches have reduced cancer-associated mortality, metastatic breast cancer can still evade therapy, particularly triple-negative breast cancer, which remains associated with high rates of cancer metastasis and has the worst clinical prognosis. Lipocalin 2 (LCN2) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Chenxia, Yang, Ke, Li, Mengjie, Huang, Weiping, Zhang, Fengxue, Wang, Hongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239117/
https://www.ncbi.nlm.nih.gov/pubmed/30519052
http://dx.doi.org/10.2147/OTT.S181223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239117/
https://www.ncbi.nlm.nih.gov/pubmed/30519052
http://dx.doi.org/10.2147/OTT.S181223

Ejemplares similares